Osborne Partners Capital Management’s Novartis NVS Stock Holding History

Osborne Partners Capital Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,725	Closed	-$225K	–	152
2020 Q1	$225K	Hold	2,725	–	–	0.06%	135
2019 Q4	$258K	Buy	2,725 +50	+2%	+$4.49K	0.05%	140
2019 Q3	$232K	Hold	2,675	–	–	0.05%	150
2019 Q2	$244K	Sell	2,675 -420	-14%	-$35.5K	0.05%	153
2019 Q1	$267K	Buy	+3,095	New	+$248K	0.05%	144
2018 Q1	–	Sell	-4,269	Closed	-$321K	–	185
2017 Q4	$321K	Sell	4,269 -611	-13%	-$46.1K	0.04%	163
2017 Q3	$375K	Sell	4,880 -2,389	-33%	-$180K	0.05%	156
2017 Q2	$544K	Sell	7,269 -83,725	-92%	-$5.93M	0.08%	130
2017 Q1	$6.06M	Sell	90,994 -1,722	-2%	-$115K	0.87%	44
2016 Q4	$6.05M	Sell	92,716 -345	-0.4%	-$22.4K	0.89%	43
2016 Q3	$6.58M	Sell	93,061 -439	-0.5%	-$32K	0.99%	33
2016 Q2	$6.91M	Sell	93,500 -2,890	-3%	-$200K	1.03%	30
2016 Q1	$6.26M	Buy	96,390 +735	+0.8%	+$50K	0.92%	39
2015 Q4	$7.38M	Sell	95,655 -5,227	-5%	-$415K	1.07%	27
2015 Q3	$8.31M	Sell	100,882 -22,343	-18%	-$1.99M	1.22%	28
2015 Q2	$10.9M	Sell	123,225 -890	-0.7%	-$81.6K	1.45%	18
2015 Q1	$11M	Sell	124,115 -27,365	-18%	-$2.43M	1.44%	20
2014 Q4	$12.6M	Buy	151,480 +3,246	+2%	+$269K	1.52%	20
2014 Q3	$12.5M	Sell	148,234 -419	-0.3%	-$33.9K	1.62%	21
2014 Q2	$12.1M	Sell	148,653 -4,210	-3%	-$331K	1.55%	22
2014 Q1	$11.6M	Buy	152,863 +1,815	+1%	+$132K	1.53%	22
2013 Q4	$10.9M	Buy	151,048 +6,939	+5%	+$482K	1.42%	23
2013 Q3	$9.91M	Sell	144,109 -1,741	-1%	-$115K	1.38%	22
2013 Q2	$9.24M	Buy	+145,850	New	+$9.49M	1.32%	25

Other funds holding NVS

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Osborne Partners Capital Management's NVS Position: Q2 2020 in Review

Osborne Partners Capital Management sold out of Novartis (NVS) in Q2 2020, closing a stake of 2,725 shares — an estimated $225K sold.

Osborne Partners Capital Management first reported a position in NVS in Q2 2013 and held it in 24 quarters. The position peaked at $12.6M in Q4 2014. 1,128 funds tracked by Wall St. Rank hold NVS as of Q2 2020.

Osborne Partners Capital Management reported no remaining Novartis position as of Q2 2020 after selling out during the quarter.
Osborne Partners Capital Management sold 2,725 Novartis shares in Q2 2020, an estimated $225K.
Osborne Partners Capital Management first reported a position in Novartis in Q2 2013 and held it in 24 quarters.
Osborne Partners Capital Management's Novartis position peaked at $12.6M in Q4 2014.
1,128 funds tracked by Wall St. Rank held Novartis as of Q2 2020.

Based on Osborne Partners Capital Management's 13F filing for Q2 2020, filed 23 Jul 2020.